| 1.6 |
4.7 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.5 |
7.4 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.3 |
12.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.3 |
7.6 |
GO:0061624 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.3 |
7.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.2 |
5.9 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.1 |
7.9 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.1 |
1.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.1 |
4.5 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.1 |
5.5 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.1 |
8.7 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.1 |
4.4 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.0 |
3.9 |
GO:0090299 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.9 |
1.9 |
GO:0034340 |
response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.9 |
3.7 |
GO:0045013 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.8 |
2.5 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.8 |
2.3 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.8 |
6.9 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.7 |
2.2 |
GO:0003168 |
Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.7 |
5.2 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 |
1.5 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.7 |
3.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 |
8.4 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.7 |
2.8 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.7 |
1.3 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.7 |
2.0 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.6 |
2.6 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.6 |
1.9 |
GO:2000627 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.6 |
0.6 |
GO:0071426 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.6 |
6.0 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.6 |
1.8 |
GO:0060278 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.6 |
2.3 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.6 |
2.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.6 |
2.9 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 |
1.7 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.5 |
1.1 |
GO:0009996 |
negative regulation of cell fate specification(GO:0009996) |
| 0.5 |
2.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.5 |
2.6 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.5 |
4.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.5 |
1.6 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.5 |
2.0 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.5 |
1.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 |
1.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.5 |
2.5 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.5 |
2.0 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.5 |
2.5 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 |
2.5 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.5 |
1.5 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.5 |
1.5 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.5 |
3.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.5 |
2.9 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.5 |
0.5 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.5 |
6.2 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.5 |
0.5 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.5 |
1.4 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.5 |
2.3 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.5 |
2.8 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 |
1.8 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 |
1.4 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 |
3.7 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 |
2.3 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.5 |
1.4 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 |
1.8 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.5 |
9.0 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.4 |
1.8 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 |
1.3 |
GO:0045362 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 |
3.6 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.4 |
1.3 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.4 |
1.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.4 |
1.8 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.4 |
1.7 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.4 |
1.3 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.4 |
1.3 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.4 |
3.0 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.4 |
1.7 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.4 |
0.8 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.4 |
1.3 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.4 |
3.4 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.4 |
0.4 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.4 |
1.2 |
GO:0009078 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.4 |
1.2 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.4 |
2.4 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.4 |
2.0 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.4 |
1.2 |
GO:0034552 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.4 |
2.3 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.4 |
1.9 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.4 |
4.5 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.4 |
1.1 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.4 |
0.4 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.4 |
2.9 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.4 |
1.8 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.4 |
1.4 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 0.3 |
2.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
1.0 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.3 |
1.0 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.3 |
1.4 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.3 |
0.3 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.3 |
5.7 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.3 |
8.0 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
3.7 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.3 |
1.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 |
0.6 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.3 |
1.0 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.3 |
0.3 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.3 |
1.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.3 |
1.3 |
GO:1901594 |
detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.3 |
4.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
2.2 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.3 |
1.5 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.3 |
1.5 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 |
1.2 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.3 |
3.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
1.2 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.3 |
0.3 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
0.9 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
1.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.3 |
1.8 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 |
1.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.3 |
1.4 |
GO:0042376 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.3 |
0.9 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.3 |
1.4 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.3 |
1.1 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.3 |
1.7 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 |
1.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.3 |
0.6 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.3 |
1.1 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.3 |
0.5 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 |
1.4 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.3 |
0.3 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.3 |
0.8 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
1.9 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.3 |
0.8 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.3 |
1.3 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 |
0.3 |
GO:0003292 |
cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 |
0.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
1.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.8 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 |
1.0 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.3 |
1.5 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.3 |
1.8 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 |
0.8 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 |
0.8 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 |
1.5 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
0.2 |
GO:0061091 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
0.5 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
1.2 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.2 |
0.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.2 |
0.7 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.2 |
0.7 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
0.7 |
GO:1900369 |
transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
| 0.2 |
1.9 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
1.0 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 |
0.7 |
GO:1902303 |
regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
3.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
2.1 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 |
0.2 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
0.5 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
0.7 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.2 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
0.2 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.2 |
0.7 |
GO:0033967 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 |
0.5 |
GO:0060573 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
0.5 |
GO:1902991 |
regulation of beta-amyloid formation(GO:1902003) regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 0.2 |
2.0 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.9 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
0.7 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
0.2 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.2 |
2.5 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 |
3.1 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.2 |
0.9 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 |
4.9 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
1.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.2 |
0.9 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.2 |
2.9 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.2 |
3.1 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.2 |
2.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
4.1 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
1.3 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.2 |
1.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.6 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 |
0.9 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.2 |
0.2 |
GO:0060825 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.2 |
0.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.6 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.2 |
0.6 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 |
0.6 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 |
0.6 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
0.4 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.2 |
0.6 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.2 |
4.1 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.2 |
0.4 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
0.4 |
GO:1903224 |
regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
0.6 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
5.2 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
1.0 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
0.6 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.2 |
0.6 |
GO:1904640 |
response to methionine(GO:1904640) |
| 0.2 |
1.6 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 |
0.2 |
GO:0052422 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 |
2.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 |
0.4 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 |
0.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.2 |
0.8 |
GO:1903719 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
1.0 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
0.8 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.2 |
0.4 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.2 |
2.3 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 |
0.2 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.2 |
2.3 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
0.8 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 |
0.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.2 |
1.9 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.2 |
GO:2000426 |
negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.2 |
0.6 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.2 |
0.6 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.2 |
0.4 |
GO:0099624 |
atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
2.1 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.2 |
1.1 |
GO:0086015 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.2 |
0.6 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.2 |
0.9 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.2 |
0.9 |
GO:0036511 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 |
0.6 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.2 |
0.4 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.2 |
0.7 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 |
0.2 |
GO:2000359 |
regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.2 |
0.4 |
GO:2000224 |
regulation of testosterone biosynthetic process(GO:2000224) |
| 0.2 |
3.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
0.2 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.2 |
1.6 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
0.5 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 |
0.9 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
0.9 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.2 |
0.5 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.2 |
0.5 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.5 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.2 |
0.4 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.2 |
0.9 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.2 |
0.9 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.2 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.2 |
0.5 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.2 |
1.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.5 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.2 |
0.7 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 |
1.0 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.2 |
1.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.9 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
1.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
1.2 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
0.8 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.2 |
0.5 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 |
0.3 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
0.7 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
0.2 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.2 |
2.2 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.2 |
0.7 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
0.7 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
1.3 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.2 |
0.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
0.5 |
GO:1903530 |
regulation of secretion by cell(GO:1903530) |
| 0.2 |
0.6 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
2.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.3 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 |
1.5 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.2 |
0.5 |
GO:0002525 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.2 |
0.5 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
0.2 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 |
0.6 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 |
4.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
0.6 |
GO:0036034 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 |
0.6 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
0.4 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.4 |
GO:0071586 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 |
0.4 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.1 |
0.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
1.0 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 |
0.1 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.1 |
0.1 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.1 |
1.0 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.9 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.9 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
0.7 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
2.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.3 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.1 |
1.0 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.8 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.4 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
0.6 |
GO:0019230 |
proprioception(GO:0019230) |
| 0.1 |
1.5 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.6 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
2.3 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.4 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.1 |
0.4 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 |
0.7 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
1.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.3 |
GO:0090194 |
negative regulation of prostatic bud formation(GO:0060686) negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 0.1 |
3.2 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.7 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 |
0.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
0.9 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.8 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.5 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.1 |
0.3 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 |
0.1 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.1 |
1.7 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
1.3 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.1 |
0.9 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
1.8 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.3 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.1 |
0.5 |
GO:1901805 |
beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
1.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.4 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.4 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.1 |
2.9 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
4.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.2 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.1 |
0.4 |
GO:1904530 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.6 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.1 |
0.5 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
0.7 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.5 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
1.2 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.7 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.9 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.2 |
GO:0052501 |
induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 |
0.2 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.1 |
0.8 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.4 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.1 |
0.5 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
1.0 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
1.3 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.2 |
GO:1902563 |
regulation of neutrophil activation(GO:1902563) |
| 0.1 |
0.5 |
GO:0031455 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 |
1.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.2 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.1 |
0.7 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.6 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.4 |
GO:0060623 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) regulation of chromosome condensation(GO:0060623) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.1 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
0.5 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.5 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.1 |
2.2 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.3 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.1 |
0.6 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 |
0.6 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
0.3 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.3 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) |
| 0.1 |
0.5 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
0.1 |
GO:1902573 |
positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 |
2.6 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
3.1 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.2 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 |
0.4 |
GO:2000852 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.1 |
0.6 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
1.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.8 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.1 |
0.7 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.1 |
0.3 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.2 |
GO:0034112 |
positive regulation of homotypic cell-cell adhesion(GO:0034112) |
| 0.1 |
0.4 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
1.0 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.1 |
0.3 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
1.6 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.3 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
1.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
1.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.3 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.1 |
0.5 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.5 |
GO:0015791 |
polyol transport(GO:0015791) glycerol transport(GO:0015793) |
| 0.1 |
0.3 |
GO:0032827 |
negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 |
0.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.3 |
GO:0032606 |
regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
| 0.1 |
2.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.4 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.5 |
GO:0090650 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 |
1.7 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.4 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 |
0.5 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
0.7 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
3.4 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 |
2.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.6 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 |
0.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.7 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
1.0 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.4 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.1 |
0.5 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
2.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
1.8 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.5 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.5 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.4 |
GO:0015770 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.6 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 |
0.7 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 |
0.3 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.1 |
0.7 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
0.2 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
1.9 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
1.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
2.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.4 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.6 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.4 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 |
0.3 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.1 |
1.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.5 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.2 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.1 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.6 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
2.5 |
GO:1901663 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
2.0 |
GO:0098926 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
2.5 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.4 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.4 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.1 |
0.6 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
1.4 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
1.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
2.0 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
1.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.4 |
GO:0006480 |
N-terminal protein amino acid methylation(GO:0006480) |
| 0.1 |
0.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.2 |
GO:0071910 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.4 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
0.3 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.4 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
1.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.9 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
0.2 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
1.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.5 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.3 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.1 |
0.3 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.3 |
GO:2000342 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 |
1.0 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.3 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.1 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 |
0.3 |
GO:1904073 |
trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.1 |
2.1 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
1.4 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 |
0.2 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.1 |
5.5 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.4 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 0.1 |
0.9 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.6 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
0.3 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
| 0.1 |
0.7 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.1 |
0.2 |
GO:0051659 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) maintenance of mitochondrion location(GO:0051659) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 |
0.2 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.5 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.3 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
1.4 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.3 |
GO:0035377 |
transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.1 |
0.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.3 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.2 |
GO:0051262 |
protein tetramerization(GO:0051262) |
| 0.1 |
0.8 |
GO:0043266 |
regulation of potassium ion transport(GO:0043266) regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 |
1.1 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.7 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.1 |
0.4 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.5 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.4 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.9 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.7 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.9 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 |
1.0 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.2 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.1 |
2.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
1.6 |
GO:0034776 |
response to histamine(GO:0034776) |
| 0.1 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.3 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 |
0.2 |
GO:1903798 |
regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
| 0.1 |
2.5 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
1.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
1.6 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
0.2 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.1 |
1.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.3 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.2 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 |
0.2 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.9 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
0.4 |
GO:0045337 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 |
0.6 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.1 |
0.8 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.4 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.1 |
1.3 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
1.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.6 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
0.5 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.6 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 |
0.2 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 |
0.8 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.4 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
1.0 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.4 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.1 |
0.1 |
GO:0048936 |
peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 |
1.0 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
2.2 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.4 |
GO:0051581 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
1.6 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.3 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
1.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.2 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 |
0.1 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.1 |
0.2 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.3 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.1 |
0.6 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.4 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.2 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 |
0.5 |
GO:0043271 |
negative regulation of ion transport(GO:0043271) |
| 0.1 |
0.1 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.1 |
0.2 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.2 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.1 |
0.6 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.7 |
GO:0010912 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.4 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
1.0 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
0.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.2 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
0.9 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.1 |
0.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.6 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.2 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.1 |
0.3 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
9.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.2 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.1 |
0.4 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 |
0.7 |
GO:0043379 |
memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
| 0.1 |
0.1 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 |
0.5 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.6 |
GO:0014048 |
regulation of glutamate secretion(GO:0014048) |
| 0.1 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.3 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.3 |
GO:0071733 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.2 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.6 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
0.2 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.1 |
0.9 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
0.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.8 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.7 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.1 |
0.9 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.3 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.1 |
0.8 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.1 |
GO:1901723 |
negative regulation of cell proliferation involved in kidney development(GO:1901723) |
| 0.1 |
0.3 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 |
0.3 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.3 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.5 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.1 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 |
0.9 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
0.3 |
GO:2001303 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.1 |
GO:0097477 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.2 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 |
0.4 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.3 |
GO:0060460 |
subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
| 0.1 |
1.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
1.1 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.3 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.7 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
1.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
2.0 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.2 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 |
0.4 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.7 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
4.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.2 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 |
2.4 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.1 |
0.2 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
1.5 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.7 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.2 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.1 |
0.1 |
GO:0071503 |
response to heparin(GO:0071503) |
| 0.1 |
0.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.4 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
1.1 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
0.2 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.5 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
1.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.6 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 |
3.0 |
GO:0006735 |
NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
2.0 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 |
1.0 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.6 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.1 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
0.2 |
GO:1902227 |
negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.1 |
0.4 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.2 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.1 |
0.6 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.1 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 0.1 |
0.1 |
GO:0072282 |
metanephric nephron tubule morphogenesis(GO:0072282) |
| 0.1 |
0.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.4 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
0.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.6 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.2 |
GO:0030730 |
regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.2 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
0.3 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.1 |
0.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.1 |
GO:0043307 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.1 |
0.2 |
GO:0002305 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.1 |
0.3 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.5 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.2 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
1.0 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.4 |
GO:0002526 |
acute inflammatory response(GO:0002526) |
| 0.1 |
1.3 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.7 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.8 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
2.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
2.1 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.1 |
0.7 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 |
0.7 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.3 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.4 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.1 |
0.4 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.2 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.1 |
0.6 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.4 |
GO:0061049 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.2 |
GO:0090034 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.3 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
1.0 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.4 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
0.4 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.5 |
GO:0051023 |
regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 |
0.0 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.1 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.0 |
0.8 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.3 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.1 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.0 |
0.2 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.0 |
0.2 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.0 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.0 |
GO:0055083 |
monovalent inorganic anion homeostasis(GO:0055083) |
| 0.0 |
0.6 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.4 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 |
0.8 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.0 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.9 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
7.8 |
GO:0072599 |
establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 |
0.4 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.0 |
2.2 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.0 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.2 |
GO:1904482 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.0 |
0.3 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.2 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
2.0 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.0 |
0.0 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.0 |
5.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
1.8 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.3 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.2 |
GO:0097369 |
sodium ion import(GO:0097369) |
| 0.0 |
0.5 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.2 |
GO:0060331 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.0 |
0.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.0 |
0.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.2 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
0.9 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
2.9 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.0 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.0 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.3 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.0 |
1.1 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 |
1.1 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.1 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
1.0 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 |
0.5 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.4 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.7 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 |
0.4 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.7 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
1.0 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.5 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.3 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.8 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.0 |
GO:0070203 |
regulation of establishment of protein localization to telomere(GO:0070203) |
| 0.0 |
0.1 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.0 |
0.1 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.6 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.0 |
0.5 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.5 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
2.2 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.2 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.4 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.2 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.4 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.0 |
0.0 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.5 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0006816 |
calcium ion transport(GO:0006816) |
| 0.0 |
1.8 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:0044108 |
calcitriol biosynthetic process from calciol(GO:0036378) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.0 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:0002923 |
regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
| 0.0 |
0.3 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.2 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 |
1.6 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
2.0 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.0 |
1.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.0 |
0.2 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.9 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 |
0.1 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.0 |
0.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.1 |
GO:0060168 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.0 |
0.2 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.1 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 |
0.3 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 |
0.2 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
1.9 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.3 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.1 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.0 |
0.3 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.3 |
GO:0006692 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.1 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 |
0.8 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.8 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.6 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.0 |
GO:1901988 |
negative regulation of cell cycle phase transition(GO:1901988) |
| 0.0 |
0.1 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.0 |
0.1 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.0 |
0.7 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.4 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.1 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.1 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.1 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
0.1 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 |
0.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.1 |
GO:0009127 |
purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
| 0.0 |
2.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.7 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.0 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.0 |
0.5 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 |
0.1 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.3 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
| 0.0 |
0.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.4 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.0 |
0.1 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.0 |
1.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.3 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.7 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.0 |
0.2 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 |
0.3 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 |
1.6 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.0 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
0.3 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.0 |
0.3 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.6 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.2 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
| 0.0 |
0.2 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.0 |
0.2 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 |
0.2 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.4 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.8 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.0 |
0.3 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.0 |
0.2 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.1 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.0 |
0.1 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.7 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.5 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.5 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.8 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.3 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.0 |
GO:1903430 |
negative regulation of neuron maturation(GO:0014043) negative regulation of cell maturation(GO:1903430) |
| 0.0 |
0.8 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.1 |
GO:0003309 |
type B pancreatic cell differentiation(GO:0003309) |
| 0.0 |
0.1 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.2 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.0 |
0.5 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.1 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.2 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.1 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 |
0.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.8 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.5 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.1 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.4 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.0 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.1 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.4 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.0 |
0.0 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
1.5 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.0 |
0.3 |
GO:0002360 |
T cell lineage commitment(GO:0002360) |
| 0.0 |
0.1 |
GO:0048808 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 |
0.1 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.0 |
0.8 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.1 |
GO:0009069 |
serine family amino acid metabolic process(GO:0009069) |
| 0.0 |
0.2 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
0.3 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.1 |
GO:0072308 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.0 |
0.1 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.1 |
GO:0044557 |
relaxation of smooth muscle(GO:0044557) |
| 0.0 |
0.1 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.1 |
GO:0034104 |
negative regulation of tissue remodeling(GO:0034104) |
| 0.0 |
0.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.0 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.8 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.3 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.0 |
0.2 |
GO:0045905 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.1 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.1 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.2 |
GO:0016446 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.2 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.0 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 |
0.1 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.0 |
0.4 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.0 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.0 |
0.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.5 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.2 |
GO:0002517 |
T cell tolerance induction(GO:0002517) |
| 0.0 |
0.1 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.0 |
0.0 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
0.1 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.8 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 |
0.0 |
GO:0002767 |
immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.0 |
0.1 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.0 |
0.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.1 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.1 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 |
0.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.3 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 |
0.2 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.0 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.1 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 |
0.0 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.0 |
0.3 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.2 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.0 |
0.3 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.0 |
0.0 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 |
0.2 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.2 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.7 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.5 |
GO:0006536 |
glutamate metabolic process(GO:0006536) |
| 0.0 |
0.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.0 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.2 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.3 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.3 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.0 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.0 |
0.2 |
GO:0007620 |
copulation(GO:0007620) |
| 0.0 |
0.1 |
GO:0060369 |
positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 |
0.0 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.0 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.0 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.1 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 |
0.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0043316 |
cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.1 |
GO:0060563 |
neuroepithelial cell differentiation(GO:0060563) |
| 0.0 |
0.1 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.1 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:0060969 |
negative regulation of gene silencing(GO:0060969) |
| 0.0 |
0.1 |
GO:0015874 |
norepinephrine transport(GO:0015874) |
| 0.0 |
0.2 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.2 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.2 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 |
0.2 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.0 |
0.1 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.0 |
0.1 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 |
0.2 |
GO:0060039 |
pericardium development(GO:0060039) |
| 0.0 |
0.0 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.0 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 |
0.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:0006064 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.0 |
0.0 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.1 |
GO:1902099 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.0 |
0.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.0 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.2 |
GO:0051931 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.1 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.0 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.0 |
0.1 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.0 |
0.3 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
0.2 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.1 |
GO:0007249 |
I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.0 |
0.1 |
GO:0071371 |
cellular response to gonadotropin stimulus(GO:0071371) |
| 0.0 |
0.1 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.0 |
0.0 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.0 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.1 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.0 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.0 |
0.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.0 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 |
0.0 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.0 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.0 |
0.0 |
GO:2000296 |
regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.0 |
0.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.2 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.1 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.0 |
0.1 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.0 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.0 |
0.0 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.0 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.0 |
0.0 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.1 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.0 |
0.0 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.7 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.1 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
| 0.0 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |